The survey addressed to citizens reveals how
during the pandemic, even among the various difficulties due to contingency,
the pharmacy was perceived as a "safe" place where to find useful
information to deal with the health emergency. More than one citizen out of
four has turned to their pharmacist for guidance on how to behave in case of
possible symptoms of Covid-19. Instead, one citizen out of ten has fallen into
the trap of fake news but has received useful information from their pharmacist
on how to "unmask" them. Moreover, pharmacies have strengthened their
home delivery and booking services for medicines, and, despite many
difficulties, have been active in ensuring the availability of all the products
needed by the population. Numerous criticisms, however, were also present. Some
pharmacies (10.4% of the sample), often the smallest ones, located in areas
where there have been greater inconveniences due to the high number of
infections, were obliged to work with "closed doors" to ensure the
safety of users, while still dispensing medicines and health products through a
counter. Some were forced to cut services due to the emergency: 15.6% of
pharmacies have suspended screening, 8.8% basic diagnostic tests/examinations,
7.9% services provided in the pharmacy by other health professionals. Still,
the restricted access to pharmacies, in 63% of cases was not perceived by
citizens as an additional difficulty in the context of the health emergency. On
the other hand, 24,5% of the respondents argued that the new working hours and
the “closed doors” function had repercussions, especially in terms of the
services offered in the pharmacy. These access difficulties gradually decreased
as the emergency phase has progressed, though they have not disappeared
completely (for 27.2% of citizens) even in the post-lockdown period (Figure 2).

Figure 2: The graph shows the
percentage of individuals who expressed themselves on the difficulty of
accessing pharmacies in the lockdown and post-lockdown period along 2020. Third
edition of the Annual Report on Pharmacies, Cittadinanzattiva, 2020.
Finally, citizens have highlighted also how,
during phase one of the emergency, 90% of pharmacies had difficulty in
procuring masks, 86% of them in providing for thermometers, saturation meters
and alcohol, 73% reported shortages of disinfectant gel and 66% of gloves. Furthermore,
44.4% of citizens, in the first phase, struggled to find in pharmacies masks at
reduced and fixed prices. The survey addressed to pharmacies shows instead the
other side of the coin. There is an almost unanimous awareness among
pharmacists that the pandemic has inevitably pushed the sector to supply
responses to citizens’ needs, first of all of a social nature, and then also of
a health nature. This fact finds substantial confirmation in the majority
(56.8%) of the individuals who responded to the survey, who recognize that
pharmacies have played, during the pandemic, both a health role, as a
protection of the National Health Service (NHS), and a social role, as a point
of reference for citizens and communities. That being said, only a third of pharmacists
(34.3%) think that their role in the area during the emergency has been
adequately recognized by institutions, while all the others are somewhat
disillusioned in this regard, also showing some frustration.

Figure
3: The
graph shows the usefulness of pharmacies in providing for different services
during the first phase of the pandemic. Third edition of the Annual Report on
Pharmacies, Cittadinanzattiva, 2020.
On the contrary, the usefulness of the pharmacy is
mostly consolidated in people’s perception: in providing advice/information
(86.3% of citizens expressed themselves), in guiding at health facilities
(71%), even in the observation of suspicious cases (59.2%), as well as for the
more traditional activities of galenic production (63.9%) and of home delivery
of medicines (78.3%). The positive side is that the pandemic still allowed the
consolidation of agreements and collaboration between pharmacies and
institutions (26.5%), civic/patient organizations (24.6%), private actors
(11.1%) and other sector stakeholders (12.6%) (Figure 3).